Wall Street analysts expect that PetIQ (NASDAQ:PETQ) will announce earnings of $0.13 per share for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for PetIQ’s earnings. The highest EPS estimate is $0.29 and the lowest is $0.02. The company is scheduled to issue its next earnings results on Tuesday, June 12th.
On average, analysts expect that PetIQ will report full year earnings of $0.85 per share for the current fiscal year, with EPS estimates ranging from $0.68 to $0.95. For the next financial year, analysts expect that the firm will report earnings of $1.11 per share, with EPS estimates ranging from $0.99 to $1.20. Zacks Investment Research’s earnings per share averages are an average based on a survey of research analysts that that provide coverage for PetIQ.
PetIQ (NASDAQ:PETQ) last announced its earnings results on Tuesday, March 13th. The company reported $0.19 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.05 by $0.14. The business had revenue of $51.93 million for the quarter, compared to analysts’ expectations of $51.63 million.
Several research analysts recently weighed in on the company. Zacks Investment Research downgraded PetIQ from a “hold” rating to a “strong sell” rating in a research note on Friday. BidaskClub downgraded PetIQ from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Jefferies Group restated a “buy” rating and set a $27.00 target price on shares of PetIQ in a research note on Monday, January 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $27.50.
Shares of PETQ stock opened at $23.23 on Wednesday. PetIQ has a 1-year low of $17.03 and a 1-year high of $28.23. The company has a current ratio of 5.99, a quick ratio of 3.56 and a debt-to-equity ratio of 0.17.
In other PetIQ news, CEO Mccord Christensen sold 20,000 shares of the business’s stock in a transaction dated Monday, April 2nd. The stock was sold at an average price of $26.22, for a total transaction of $524,400.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO John Newland sold 5,500 shares of the business’s stock in a transaction dated Monday, March 19th. The shares were sold at an average price of $24.83, for a total value of $136,565.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 65,500 shares of company stock worth $1,657,765.
A number of institutional investors have recently bought and sold shares of PETQ. American International Group Inc. purchased a new stake in PetIQ during the 3rd quarter valued at about $131,000. Keeler Thomas Management LLC purchased a new stake in PetIQ during the 4th quarter valued at about $131,000. Wells Fargo & Company MN purchased a new stake in PetIQ during the 3rd quarter valued at about $204,000. Gotham Asset Management LLC purchased a new stake in PetIQ during the 4th quarter valued at about $264,000. Finally, California State Teachers Retirement System purchased a new stake in PetIQ during the 3rd quarter valued at about $320,000. Institutional investors and hedge funds own 37.02% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Brokerages Expect PetIQ (PETQ) Will Announce Earnings of $0.13 Per Share” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/04/09/brokerages-expect-petiq-petq-will-announce-earnings-of-0-13-per-share.html.
PetIQ Company Profile
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Get a free copy of the Zacks research report on PetIQ (PETQ)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.